Written by
International Journal of Pharmacology and Clinical Sciences, 2022, 11, 2, 31-35.
DOI: 10.5530/ijpcs.2022.11.7
Published: June 2022
Type: Review Article
Authors: Yousef Ahmed Alomi, Amal Hassan Al-Najjar, Ghudair Tashan Alanazi, Maha Hussein
Almadany, and Abeer Hussin Almasoudi
Author(s) affiliations:
Yousef Ahmed Alomi*, BSc.Pharm, MSc. Clin Pharm, BCPS, BCNSP, DiBA, CDE Critical Care Clinical Pharmacists, TPN Clinical Pharmacist, Freelancer Business Planner, Content Editor, and Data Analyst, Riyadh, Saudi Arabia.
Amal Hassan Al-Najjar, BSc, MSc, Drug and Poison Information Center, Security Forces Hospitals, Riyadh, Saudi Arabia.
Ghudair Tashan Alanazi, BSc. Pharm, Pharm.D, MSc. Clin Pharm, Diploma of Epid, Critical Care Clinical Pharmacist, Internal Medicine Clinical Pharmacist, MOH, Hafrbatin, Saudi Arabia.
Maha Hussein Almadany, BSc. Pharm, Health Care Quality Management Professional Diploma (HCQM), Pharmacy Quality Department, King Salman bin Abdulaziz Medical City, Al Madina Al Monwarah, Saudi Arabia.
Abeer Hussin Almasoudi, BSc.Pharm, Director, Administration of Research and Studies, Ministry of Health, Tabuk, Saudi Arabia.
Abstract
Objectives: This study illustrates the Research policy of Cross-Sectional Studies in Pharmaceutical Care Services as a new initiative in Saudi Arabia. Methods: This article is a narrative review of pharmacy research. Literature researched specific research policies and procedures in pharmacy practice using a variety of databases, including PubMed, Medline, and Google Scholar. The period covered for the search is from the 1960s to October 2021. The terms used are in the English language and encompass narrative reviews, systemic reviews, meta-analyses, and guidelines. The search term includes all hospital and community pharmacy-related services. Besides, there are national and international guidelines for conducting general research in hospital practice. The pharmacy research committee was formed and comprised numerous expert members, including clinical pharmacists, pharmacists who specialise in drug information, and clinical research specialists. A member drafted the policy’s guidelines, which were then reviewed and corrected by another member. The research specialist made the third revision. The topic emphasises the Pharmacy Research policy of cross-sectional studies design. Results: Pharmacy Research’s policy on cross-sectional studies design in pharmacy practice covered a variety of topics. This includes an examination of the advantages and disadvantages of cross- sectional studies design, as well as the procedures for conducting cross-sectional research in pharmaceutical care services. Conclusion: A novel initiative in pharmacy practice is the development of a pharmacy research strategy that governs the design of cross-sectional studies. The cross-sectional studies used to develop pharmacy policies increased the number and quality of pharmacy research at public and private healthcare organisations. Thus, the cross-sectional design in pharmacy research policy is a basic foundation to implement in Saudi Arabia.
Keywords: Cross-sectional, Pharmacy, Policy, Research, Saudi Arabia